The BMJ alleges grave irregularities in the billion dollar asset Phase 3 studies

I am not sure why the BMJ chose this path to raise concerns instead of filing complaints with the regulators or file whistle blower lawsuites?

Does the BMJ stand to gain by the benefits of sensationalist reporting in terms of tangible circulation numbers and intangible 'prestige factors'?

After all many of the 'irregularities' may have benign explanatio…